The biosimulation market is expected to reach USD 2,107.99 Million by 2020 from USD 1,034.93 Million in 2015, growing at a CAGR of 15.29% between 2015 and 2020. A strong trend of R&D investments in biotechnology and pharmaceutical industries will majorly drive the growth of the market.
Complete report on Biosimulation Market spread across 150 pages, Profiling 11 Companies and supported with 75 Tables and 64 Figures is now available at http://www.reportsnreports.com/reports/199952-global-biosimulation-technology-market-for-drug-discovery-development-2012-2017-.html .
Other growth factors include the need to curtail drug discovery & development costs, growth in the biologics and biosimilars markets, the increased use of personalized medicines, technological advancements, and periodic product upgradation. The increased applications of biosimulation in the defense, industrial bioprocessing, nutraceuticals, and agri-food production will provide opportunities for market growth.
Global Biosimulation Market, by End User
- Academic and Government Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organization
- Regulatory Authorities
- Other End Users
This report segments the global biosimulation market by product, application, and end user. The global market product segments are software and services. The software segment is further classified into molecular modeling and simulation software, PBPK modeling and simulation software, PK/PD modeling and simulation software, trail design software, toxicity prediction software, and other software (QSP, visualizing and analytical software). The services segment includes into in-house services and external/contract services. In 2015, the software segment is expected to account for the largest share of the global biosimulation market.
Sample copy of this research is available now
Based on applications, the market is segmented into drug discovery, drug development, and others (defense, industrial bioprocessing, nutraceuticals, and agri-food production). The drug development application segment is further classified into preclinical testing and clinical trials. The drug discovery segment is divided into target identification & validation and lead identification & optimization.
The major players in the global biosimulation market are Certara USA, Inc. (U.S.), Simulation Plus Inc. (U.S.), Dassault Systèmes SA (France), Schrödinger Inc. (U.S.), Advanced Chemistry Development, Inc. (Canada), Chemical Computing Group, Inc. (Canada), Physiomics PLC (U.K.), Entelos Holding Corporation (U.S.), Rhenovia Pharma Ltd. (France), and Genedata AG (Switzerland).
Click now for more Details, Quiries and Discount, Other Information on this study “Biosimulation Market by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), Application (Drug Discovery & Development, Preclinical, Clinical Trial) & by End Users - Global Forecast to 2020” research @ http://www.reportsnreports.com/contacts/discount.aspx?name=199952 .
The end users for this market are academic and government research institutes, pharmaceutical and biotechnology companies, contract research organizations (CROs), regulatory authorities, and other end users (defense, nutraceuticals companies, and food and agricultural companies).
Based on geography, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The major drivers for the market include the strong trend of R&D investments in biotechnology and pharmaceutical industries; the need to curtail drug discovery & development costs; growth in the biologics and biosimilars market; increased use of personalized medicines; technological advancements; and the trend of periodic product upgradation.
Explore more reports on Medical Devices at www.reportsnreports.com/market-research/medical-devices/ .
ReportsandReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013